25 XP   0   0   10

Celon Pharma SA
Buy, Hold or Sell?

Let's analyse Celon Pharma SA together

PenkeI guess you are interested in Celon Pharma SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Celon Pharma SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Celon Pharma SA

I send you an email if I find something interesting about Celon Pharma SA.

Quick analysis of Celon Pharma SA (30 sec.)










What can you expect buying and holding a share of Celon Pharma SA? (30 sec.)

How much money do you get?

How much money do you get?
zł0.29
When do you have the money?
1 year
How often do you get paid?
85.7%

What is your share worth?

Current worth
zł9.39
Expected worth in 1 year
zł3.57
How sure are you?
71.4%

+ What do you gain per year?

Total Gains per Share
zł-4.67
Return On Investment
-30.6%

For what price can you sell your share?

Current Price per Share
zł15.24
Expected price per share
zł14.64 - zł15.82
How sure are you?
50%

1. Valuation of Celon Pharma SA (5 min.)




Live pricePrice per Share (EOD)

zł15.24

Intrinsic Value Per Share

zł-9.72 - zł5.61

Total Value Per Share

zł-0.32 - zł15.01

2. Growth of Celon Pharma SA (5 min.)




Is Celon Pharma SA growing?

Current yearPrevious yearGrowGrow %
How rich?$118.9m$137.3m-$18.4m-15.5%

How much money is Celon Pharma SA making?

Current yearPrevious yearGrowGrow %
Making money-$9.7m-$2.8m-$6.8m-70.4%
Net Profit Margin-24.3%-6.8%--

How much money comes from the company's main activities?

3. Financial Health of Celon Pharma SA (5 min.)




What can you expect buying and holding a share of Celon Pharma SA? (5 min.)

Welcome investor! Celon Pharma SA's management wants to use your money to grow the business. In return you get a share of Celon Pharma SA.

What can you expect buying and holding a share of Celon Pharma SA?

First you should know what it really means to hold a share of Celon Pharma SA. And how you can make/lose money.

Speculation

The Price per Share of Celon Pharma SA is zł15.24. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Celon Pharma SA.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Celon Pharma SA, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is zł9.39. Based on the TTM, the Book Value Change Per Share is zł-1.46 per quarter. Based on the YOY, the Book Value Change Per Share is zł4.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is zł0.29 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Celon Pharma SA.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.19-1.3%-0.19-1.3%-0.06-0.4%-0.01-0.1%0.040.2%
Usd Book Value Change Per Share-0.36-2.4%-0.36-2.4%1.026.7%0.040.3%0.332.2%
Usd Dividend Per Share0.070.5%0.070.5%0.020.1%0.040.2%0.030.2%
Usd Total Gains Per Share-0.29-1.9%-0.29-1.9%1.036.8%0.070.5%0.362.4%
Usd Price Per Share3.48-3.48-8.22-7.87-6.89-
Price to Earnings Ratio-18.22--18.22--145.82--439.64--303.84-
Price-to-Total Gains Ratio-12.02--12.02-7.96-129.68-108.94-
Price to Book Ratio1.49-1.49-3.06-3.73-3.26-
Price-to-Total Gains Ratio-12.02--12.02-7.96-129.68-108.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.777996
Number of shares264
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.070.04
Usd Book Value Change Per Share-0.360.04
Usd Total Gains Per Share-0.290.07
Gains per Quarter (264 shares)-76.3419.53
Gains per Year (264 shares)-305.3678.14
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
176-381-315374168
2152-762-6207582146
3228-1144-925112122224
4304-1525-1230149163302
5379-1906-1535187204380
6455-2287-1840224245458
7531-2669-2145261286536
8607-3050-2450299326614
9683-3431-2755336367692
10759-3812-3060373408770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.03.00.057.1%4.03.00.057.1%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.03.00.057.1%4.03.00.057.1%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.01.085.7%6.00.01.085.7%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.02.00.071.4%5.02.00.071.4%

Fundamentals of Celon Pharma SA

About Celon Pharma SA

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.

Fundamental data was last updated by Penke on 2024-04-10 01:43:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Celon Pharma SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Celon Pharma SA earns for each zł1 of revenue.

  • Above 10% is considered healthy but always compare Celon Pharma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -24.3% means that zł-0.24 for each zł1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Celon Pharma SA:

  • The MRQ is -24.3%. The company is making a huge loss. -2
  • The TTM is -24.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-24.3%TTM-24.3%0.0%
TTM-24.3%YOY-6.8%-17.4%
TTM-24.3%5Y3.9%-28.2%
5Y3.9%10Y10.4%-6.5%
1.1.2. Return on Assets

Shows how efficient Celon Pharma SA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Celon Pharma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • -6.5% Return on Assets means that Celon Pharma SA generated zł-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Celon Pharma SA:

  • The MRQ is -6.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.5%TTM-6.5%0.0%
TTM-6.5%YOY-1.6%-4.8%
TTM-6.5%5Y0.6%-7.1%
5Y0.6%10Y4.3%-3.7%
1.1.3. Return on Equity

Shows how efficient Celon Pharma SA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Celon Pharma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • -8.2% Return on Equity means Celon Pharma SA generated zł-0.08 for each zł1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Celon Pharma SA:

  • The MRQ is -8.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.2%TTM-8.2%0.0%
TTM-8.2%YOY-2.1%-6.1%
TTM-8.2%5Y1.1%-9.2%
5Y1.1%10Y6.9%-5.8%

1.2. Operating Efficiency of Celon Pharma SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Celon Pharma SA is operating .

  • Measures how much profit Celon Pharma SA makes for each zł1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Celon Pharma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated zł0.00  for each zł1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Celon Pharma SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-6.2%+6.2%
TTM-5Y5.0%-5.0%
5Y5.0%10Y7.1%-2.0%
1.2.2. Operating Ratio

Measures how efficient Celon Pharma SA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.65 means that the operating costs are zł1.65 for each zł1 in net sales.

Let's take a look of the Operating Ratio trends of Celon Pharma SA:

  • The MRQ is 1.645. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.645. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.645TTM1.6450.000
TTM1.645YOY1.426+0.219
TTM1.6455Y1.229+0.416
5Y1.22910Y0.963+0.266

1.3. Liquidity of Celon Pharma SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Celon Pharma SA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.04 means the company has zł2.04 in assets for each zł1 in short-term debts.

Let's take a look of the Current Ratio trends of Celon Pharma SA:

  • The MRQ is 2.040. The company is able to pay all its short-term debts. +1
  • The TTM is 2.040. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.040TTM2.0400.000
TTM2.040YOY3.227-1.187
TTM2.0405Y4.536-2.495
5Y4.53610Y5.332-0.796
1.3.2. Quick Ratio

Measures if Celon Pharma SA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Celon Pharma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.93 means the company can pay off zł0.93 for each zł1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Celon Pharma SA:

  • The MRQ is 0.935. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.935. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.935TTM0.9350.000
TTM0.935YOY1.209-0.275
TTM0.9355Y3.357-2.423
5Y3.35710Y4.255-0.898

1.4. Solvency of Celon Pharma SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Celon Pharma SA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Celon Pharma SA to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.21 means that Celon Pharma SA assets are financed with 21.2% credit (debt) and the remaining percentage (100% - 21.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Celon Pharma SA:

  • The MRQ is 0.212. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.212. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.212TTM0.2120.000
TTM0.212YOY0.217-0.004
TTM0.2125Y0.246-0.034
5Y0.24610Y0.257-0.010
1.4.2. Debt to Equity Ratio

Measures if Celon Pharma SA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Celon Pharma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 27.0% means that company has zł0.27 debt for each zł1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Celon Pharma SA:

  • The MRQ is 0.270. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.270. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.270TTM0.2700.000
TTM0.270YOY0.276-0.007
TTM0.2705Y0.335-0.065
5Y0.33510Y0.363-0.028

2. Market Valuation of Celon Pharma SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every zł1 in earnings Celon Pharma SA generates.

  • Above 15 is considered overpriced but always compare Celon Pharma SA to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -18.22 means the investor is paying zł-18.22 for every zł1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Celon Pharma SA:

  • The EOD is -19.811. Based on the earnings, the company is expensive. -2
  • The MRQ is -18.225. Based on the earnings, the company is expensive. -2
  • The TTM is -18.225. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.811MRQ-18.225-1.586
MRQ-18.225TTM-18.2250.000
TTM-18.225YOY-145.819+127.594
TTM-18.2255Y-439.644+421.419
5Y-439.64410Y-303.837-135.806
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Celon Pharma SA:

  • The EOD is -20.154. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -18.541. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -18.541. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.154MRQ-18.541-1.613
MRQ-18.541TTM-18.5410.000
TTM-18.541YOY650.970-669.511
TTM-18.5415Y97.906-116.447
5Y97.90610Y26.685+71.221
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Celon Pharma SA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.49 means the investor is paying zł1.49 for each zł1 in book value.

Let's take a look of the Price to Book Ratio trends of Celon Pharma SA:

  • The EOD is 1.622. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.492. Based on the equity, the company is underpriced. +1
  • The TTM is 1.492. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.622MRQ1.492+0.130
MRQ1.492TTM1.4920.000
TTM1.492YOY3.055-1.563
TTM1.4925Y3.733-2.241
5Y3.73310Y3.260+0.473
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Celon Pharma SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.456-1.4560%4.103-135%0.156-1034%1.342-209%
Book Value Per Share--9.3949.3940%10.851-13%8.900+6%7.870+19%
Current Ratio--2.0402.0400%3.227-37%4.536-55%5.332-62%
Debt To Asset Ratio--0.2120.2120%0.217-2%0.246-14%0.257-17%
Debt To Equity Ratio--0.2700.2700%0.276-2%0.335-20%0.363-26%
Dividend Per Share--0.2900.2900%0.062+370%0.143+103%0.123+135%
Eps---0.769-0.7690%-0.227-70%-0.040-95%0.147-622%
Free Cash Flow Per Share---0.756-0.7560%0.051-1585%-0.680-10%-0.586-22%
Free Cash Flow To Equity Per Share---0.756-0.7560%3.594-121%-0.022-97%-0.074-90%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--5.612--------
Intrinsic Value_10Y_min---9.718--------
Intrinsic Value_1Y_max---0.208--------
Intrinsic Value_1Y_min---0.761--------
Intrinsic Value_3Y_max---0.039--------
Intrinsic Value_3Y_min---2.485--------
Intrinsic Value_5Y_max--0.839--------
Intrinsic Value_5Y_min---4.412--------
Market Cap778101060.000+8%715812130.000715812130.0000%1692522975.000-58%1620226971.000-56%1418422507.857-50%
Net Profit Margin---0.243-0.2430%-0.068-72%0.039-715%0.104-333%
Operating Margin----0%-0.0620%0.050-100%0.071-100%
Operating Ratio--1.6451.6450%1.426+15%1.229+34%0.963+71%
Pb Ratio1.622+8%1.4921.4920%3.055-51%3.733-60%3.260-54%
Pe Ratio-19.811-9%-18.225-18.2250%-145.819+700%-439.644+2312%-303.837+1567%
Price Per Share15.240+8%14.02014.0200%33.150-58%31.734-56%27.781-50%
Price To Free Cash Flow Ratio-20.154-9%-18.541-18.5410%650.970-103%97.906-119%26.685-169%
Price To Total Gains Ratio-13.065-9%-12.019-12.0190%7.960-251%129.676-109%108.942-111%
Quick Ratio--0.9350.9350%1.209-23%3.357-72%4.255-78%
Return On Assets---0.065-0.0650%-0.016-75%0.006-1096%0.043-249%
Return On Equity---0.082-0.0820%-0.021-74%0.011-879%0.069-220%
Total Gains Per Share---1.166-1.1660%4.164-128%0.298-491%1.465-180%
Usd Book Value--118904243.400118904243.4000%137337095.800-13%112643269.597+6%99606730.320+19%
Usd Book Value Change Per Share---0.361-0.3610%1.017-135%0.039-1034%0.333-209%
Usd Book Value Per Share--2.3292.3290%2.690-13%2.206+6%1.951+19%
Usd Dividend Per Share--0.0720.0720%0.015+370%0.035+103%0.031+135%
Usd Eps---0.191-0.1910%-0.056-70%-0.010-95%0.037-622%
Usd Free Cash Flow---9570675.300-9570675.3000%644540.000-1585%-8601527.887-10%-6357770.669-34%
Usd Free Cash Flow Per Share---0.187-0.1870%0.013-1585%-0.168-10%-0.145-22%
Usd Free Cash Flow To Equity Per Share---0.187-0.1870%0.891-121%-0.006-97%-0.018-90%
Usd Market Cap192891252.774+8%177449827.027177449827.0270%419576445.503-58%401654266.111-56%351626939.698-50%
Usd Price Per Share3.778+8%3.4763.4760%8.218-58%7.867-56%6.887-50%
Usd Profit---9736768.300-9736768.3000%-2877375.300-70%607010.915-1704%2657438.420-466%
Usd Revenue--40138728.50040138728.5000%42033676.100-5%34618541.872+16%33008238.435+22%
Usd Total Gains Per Share---0.289-0.2890%1.032-128%0.074-491%0.363-180%
 EOD+5 -3MRQTTM+0 -0YOY+7 -275Y+11 -2410Y+11 -24

3.2. Fundamental Score

Let's check the fundamental score of Celon Pharma SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-19.811
Price to Book Ratio (EOD)Between0-11.622
Net Profit Margin (MRQ)Greater than0-0.243
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.935
Current Ratio (MRQ)Greater than12.040
Debt to Asset Ratio (MRQ)Less than10.212
Debt to Equity Ratio (MRQ)Less than10.270
Return on Equity (MRQ)Greater than0.15-0.082
Return on Assets (MRQ)Greater than0.05-0.065
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Celon Pharma SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.007
Ma 20Greater thanMa 5015.076
Ma 50Greater thanMa 10015.095
Ma 100Greater thanMa 20015.315
OpenGreater thanClose15.160
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in PLN. All numbers in thousands.

Summary
Total Assets608,935
Total Liabilities129,289
Total Stockholder Equity479,646
 As reported
Total Liabilities 129,289
Total Stockholder Equity+ 479,646
Total Assets = 608,935

Assets

Total Assets608,935
Total Current Assets237,581
Long-term Assets371,354
Total Current Assets
Cash And Cash Equivalents 82,902
Short-term Investments 81,722
Net Receivables 27,111
Inventory 38,385
Other Current Assets 871
Total Current Assets  (as reported)237,581
Total Current Assets  (calculated)230,991
+/- 6,590
Long-term Assets
Property Plant Equipment 306,794
Goodwill -5,324
Intangible Assets 28,121
Long-term Assets Other 379
Long-term Assets  (as reported)371,354
Long-term Assets  (calculated)329,970
+/- 41,384

Liabilities & Shareholders' Equity

Total Current Liabilities116,440
Long-term Liabilities12,849
Total Stockholder Equity479,646
Total Current Liabilities
Accounts payable 18,306
Other Current Liabilities 14,396
Total Current Liabilities  (as reported)116,440
Total Current Liabilities  (calculated)32,702
+/- 83,738
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt26,822
Long-term Liabilities Other -21,475
Long-term Liabilities  (as reported)12,849
Long-term Liabilities  (calculated)5,347
+/- 7,502
Total Stockholder Equity
Total Stockholder Equity (as reported)479,646
Total Stockholder Equity (calculated)0
+/- 479,646
Other
Capital Stock5,104
Common Stock Shares Outstanding 51,035
Net Invested Capital 479,646
Net Working Capital 121,141
Property Plant and Equipment Gross 482,658



Balance Sheet

Currency in PLN. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
168,289
464,321
525,050
563,668
591,346
531,888
707,138
608,935
608,935707,138531,888591,346563,668525,050464,321168,289
   > Total Current Assets 
44,946
270,162
254,546
213,751
143,576
119,242
278,701
237,581
237,581278,701119,242143,576213,751254,546270,16244,946
       Cash And Cash Equivalents 
2,780
220,765
201,355
147,998
66,692
43,978
147,796
82,902
82,902147,79643,97866,692147,998201,355220,7652,780
       Short-term Investments 
0
0
0
0
0
13
79,755
81,722
81,72279,7551300000
       Net Receivables 
16,753
25,431
34,836
42,146
45,778
32,528
24,674
27,111
27,11124,67432,52845,77842,14634,83625,43116,753
       Inventory 
19,491
19,869
18,356
23,607
30,062
29,760
23,376
38,385
38,38523,37629,76030,06223,60718,35619,86919,491
       Other Current Assets 
1,363
917
410
2,015
1,044
3,483
529
871
8715293,4831,0442,0154109171,363
   > Long-term Assets 
0
0
0
349,917
447,770
584,725
428,437
371,354
371,354428,437584,725447,770349,917000
       Property Plant Equipment 
100,508
112,076
121,311
171,638
242,785
329,141
329,208
306,794
306,794329,208329,141242,785171,638121,311112,076100,508
       Intangible Assets 
2,973
3,357
2,639
7,410
6,162
41,096
29,171
28,121
28,12129,17141,0966,1627,4102,6393,3572,973
       Long-term Assets Other 
0
0
0
0
0
0
0
379
3790000000
> Total Liabilities 
67,471
61,820
85,203
114,939
146,305
187,356
153,136
129,289
129,289153,136187,356146,305114,93985,20361,82067,471
   > Total Current Liabilities 
36,552
14,243
18,972
19,717
25,981
114,146
86,363
116,440
116,44086,363114,14625,98119,71718,97214,24336,552
       Short Long Term Debt 
0
0
0
0
0
12,837
0
0
0012,83700000
       Accounts payable 
0
0
5,928
9,004
7,363
18,417
11,872
18,306
18,30611,87218,4177,3639,0045,92800
       Other Current Liabilities 
0
0
10,451
9,498
15,659
72,634
64,814
14,396
14,39664,81472,63415,6599,49810,45100
   > Long-term Liabilities 
0
0
0
95,222
120,322
198,401
66,773
12,849
12,84966,773198,401120,32295,222000
       Other Liabilities 
0
0
64,523
95,222
120,130
64,052
58,419
0
058,41964,052120,13095,22264,52300
       Deferred Long Term Liability 
0
0
0
0
4,080
2,720
1,360
0
01,3602,7204,0800000
> Total Stockholder Equity
100,817
402,501
439,847
448,729
445,040
344,532
554,002
479,646
479,646554,002344,532445,040448,729439,847402,501100,817
   Common Stock
3,000
4,500
4,500
4,500
4,500
4,500
5,100
0
05,1004,5004,5004,5004,5004,5003,000
   Retained Earnings 
100,387
131,195
149,160
39,767
172,342
-58,574
-91,674
-119,788
-119,788-91,674-58,574172,34239,767149,160131,195100,387
   Capital Surplus 
0
234,452
234,452
234,452
234,452
0
0
0
000234,452234,452234,452234,4520
   Treasury Stock00000000
   Other Stockholders Equity 
-2,570
0
51,736
170,011
33,747
5,482
27,066
0
027,0665,48233,747170,01151,7360-2,570



Balance Sheet

Currency in PLN. All numbers in thousands.




Cash Flow

Currency in PLN. All numbers in thousands.




Income Statement

Currency in PLN. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue167,890
Cost of Revenue-69,492
Gross Profit98,39898,398
 
Operating Income (+$)
Gross Profit98,398
Operating Expense-194,499
Operating Income-26,609-96,101
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense194,4990
 
Net Interest Income (+$)
Interest Income1,065
Interest Expense-2,589
Other Finance Cost-1,018
Net Interest Income-506
 
Pretax Income (+$)
Operating Income-26,609
Net Interest Income-506
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-17,401-26,609
EBIT - interestExpense = -2,589
-25,140
-22,551
Interest Expense2,589
Earnings Before Interest and Taxes (EBIT)--14,812
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-17,401
Tax Provision-7,739
Net Income From Continuing Ops-25,140-25,140
Net Income-25,140
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-506
 

Technical Analysis of Celon Pharma SA
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Celon Pharma SA. The general trend of Celon Pharma SA is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Celon Pharma SA's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Celon Pharma SA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 15.46 < 15.46 < 15.82.

The bearish price targets are: 14.70 > 14.70 > 14.64.

Tweet this
Celon Pharma SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Celon Pharma SA. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Celon Pharma SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Celon Pharma SA. The current macd is -0.0285666.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Celon Pharma SA price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Celon Pharma SA. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Celon Pharma SA price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Celon Pharma SA Daily Moving Average Convergence/Divergence (MACD) ChartCelon Pharma SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Celon Pharma SA. The current adx is 11.71.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Celon Pharma SA shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Celon Pharma SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Celon Pharma SA. The current sar is 14.71.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Celon Pharma SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Celon Pharma SA. The current rsi is 55.01. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Celon Pharma SA Daily Relative Strength Index (RSI) ChartCelon Pharma SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Celon Pharma SA. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Celon Pharma SA price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Celon Pharma SA Daily Stochastic Oscillator ChartCelon Pharma SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Celon Pharma SA. The current cci is 54.32.

Celon Pharma SA Daily Commodity Channel Index (CCI) ChartCelon Pharma SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Celon Pharma SA. The current cmo is 18.81.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Celon Pharma SA Daily Chande Momentum Oscillator (CMO) ChartCelon Pharma SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Celon Pharma SA. The current willr is -28.94736842.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Celon Pharma SA is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Celon Pharma SA Daily Williams %R ChartCelon Pharma SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Celon Pharma SA.

Celon Pharma SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Celon Pharma SA. The current atr is 0.33569725.

Celon Pharma SA Daily Average True Range (ATR) ChartCelon Pharma SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Celon Pharma SA. The current obv is 602,017.

Celon Pharma SA Daily On-Balance Volume (OBV) ChartCelon Pharma SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Celon Pharma SA. The current mfi is 67.89.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Celon Pharma SA Daily Money Flow Index (MFI) ChartCelon Pharma SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Celon Pharma SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Celon Pharma SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Celon Pharma SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.007
Ma 20Greater thanMa 5015.076
Ma 50Greater thanMa 10015.095
Ma 100Greater thanMa 20015.315
OpenGreater thanClose15.160
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Celon Pharma SA with someone you think should read this too:
  • Are you bullish or bearish on Celon Pharma SA? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Celon Pharma SA? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Celon Pharma SA

I send you an email if I find something interesting about Celon Pharma SA.


Comments

How you think about this?

Leave a comment

Stay informed about Celon Pharma SA.

Receive notifications about Celon Pharma SA in your mailbox!